25/01/2023

Second Quarter FY23 Conference Call

11/12/2022

Professor Alex Sinclair Radio Interview (2GB) on IIH EVOLVE Phase III Clinical Trial

01/12/2022

Presentation to MST Financial Late-Stage Development Biotech Virtual Forum

29/11/2022

Professor Alex Sinclair Radio Interview on IIH EVOLVE Phase III Clinical Trial

28/11/2022

Professor Alex Sinclair Interview with Small Caps on IIH EVOLVE Phase III Clinical Trial

04/11/2022

Presentation to Emerging ASX Gems Conference – Dr Tom Duthy

27/10/2022

First Quarter FY23 Investor Call

14/09/2022

Presentation to ASX Small to Mid Cap Investor Conference September 2022

11/07/2022

Investor Presentation

06/07/2022

Fourth Quarter FY22 Investor Call

19/04/2022

Third Quarter FY22 Investor Call

24/03/2022

Presentation to Tech/Biotech Broker Briefing 24 March 2022

24/01/2022

Invex Quarterly Update Investor Conference Call

25/11/2021

Annual General Meeting of Shareholders

11/11/2021

Bell Potter Healthcare Conference Presentation

04/11/2021

Clinical and Regulatory Strategy Update

30/09/2021

Small Caps Interview – Dr Tom Duthy

27/09/2021

Collaboration and Manufacturing Agreement with Peptron – Investor Presentation

08/04/2021

8 April 2021 – General Meeting of Shareholders

18/03/2021

NWR Small Caps Conference Presentation – Dr Tom Duthy

22/02/2021

Investor Presentation – February 2021

30/11/2020

Bell Potter Healthcare Conference Presentation – Dr Tom Duthy

26/11/2020

Bell Potter Healthcare Conference Presentation

26/11/2020

Professor Alex Sinclair interview for Bell Potter Healthcare Conference

18/11/2020

Invex 2020 AGM Presentation

05/11/2020

NWR Small Caps Virtual Investment Conference

23/07/2020

Dr Jason Loveridge, Invex Chairman, presents a regulatory update

25/05/2020

Prof. Alex Sinclair presents the Phase II clinical trial results

22/05/2020

Phase II Clinical Results and Capital Raising

01/05/2020

Virtual Health Conference

09/03/2020

March Business Update

20/11/2019

Open Briefing Video

19/11/2019

Open Briefing Presentation

05/07/2019

Successfully raises $A12 million and lists on ASX